<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03182491</url>
  </required_header>
  <id_info>
    <org_study_id>2016/1635</org_study_id>
    <nct_id>NCT03182491</nct_id>
  </id_info>
  <brief_title>Mechanisms of Anaphylaxis</brief_title>
  <acronym>ANAMEK</acronym>
  <official_title>Mechanisms of Anaphylaxis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore different mechanisms for anaphylaxis and find novel
      biomarkers for this hypersensitivity syndrome. The study participants are patients with
      anaphylaxis, patients with mild allergic reactions, and patients with febrile transfusion
      reactions. The investigators will also include a group of healthy controls.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>Clarify mechanisms for anaphylaxis and establish biomarkers for this syndrome</measure>
    <time_frame>2 days</time_frame>
    <description>Immunological/nonimmunological mechanism</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Anaphylaxis</condition>
  <condition>Allergy</condition>
  <condition>Transfusion Reaction</condition>
  <condition>Febrile Transfusion Reaction</condition>
  <arm_group>
    <arm_group_label>Anaphylaxis</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Febrile transfusion reactions</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild allergic reactions</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Biomarkers (platelet activating factor [PAF], anaphylatoxins) and basophil activation test (BAT)</intervention_name>
    <description>Analysis of biomarkers and basophil activation test</description>
    <arm_group_label>Anaphylaxis</arm_group_label>
    <arm_group_label>Febrile transfusion reactions</arm_group_label>
    <arm_group_label>Mild allergic reactions</arm_group_label>
    <arm_group_label>Healthy controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum samples, plasma samples, full blood-samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        According to the specific cohort:

          1. Diagnosis of anaphylaxis

          2. Mild allergic reaction

          3. Febrile transfusion reaction

          4. Healthy, no known allergic disease

        Exclusion Criteria:

        Suspicion or diagnosed sepsis Children
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Torunn O Apelseth, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Haukeland University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morten Y Isaksen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Haukeland University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morten Y Isaksen, MD</last_name>
    <phone>+4799769478</phone>
    <email>morten.yung.isaksen@helse-bergen.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Torunn O Apelseth, MD, PhD</last_name>
    <phone>+4794842045</phone>
    <email>torunn.oveland.apelseth@helse-bergen.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Y Isaksen, MD</last_name>
      <phone>+4799769478</phone>
      <email>morten.yung.isaksen@helse-bergen.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>September 14, 2017</last_update_submitted>
  <last_update_submitted_qc>September 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Platelet activating factor</keyword>
  <keyword>Basophil activation test</keyword>
  <keyword>Anaphylatoxins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anaphylaxis</mesh_term>
    <mesh_term>Transfusion Reaction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anaphylatoxins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

